These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28556962)

  • 1. Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging study.
    Thornton S; Valenzuela G; Baidoo C; Fossler MJ; Montague TH; Clayton L; Powell M; Snidow J; Stier B; Soergel D
    Br J Clin Pharmacol; 2017 Oct; 83(10):2283-2291. PubMed ID: 28556962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study.
    Thornton S; Miller H; Valenzuela G; Snidow J; Stier B; Fossler MJ; Montague TH; Powell M; Beach KJ
    Br J Clin Pharmacol; 2015 Oct; 80(4):740-9. PubMed ID: 25819462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
    Saade GR; Shennan A; Beach KJ; Hadar E; Parilla BV; Snidow J; Powell M; Montague TH; Liu F; Komatsu Y; McKain L; Thornton S
    Am J Perinatol; 2021 Aug; 38(S 01):e309-e317. PubMed ID: 32380566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban.
    Marchand G; Blumrick R; Ruuska AD; Ware K; Masoud AT; King A; Ruther S; Brazil G; Cieminski K; Calteux N; Ulibarri H; Sainz K
    Curr Med Res Opin; 2021 Sep; 37(9):1677-1688. PubMed ID: 34134590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.
    Caltabiano S; Magee MH; Liu F; Beach KJ
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):59-66. PubMed ID: 28419732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin receptor antagonists for inhibiting preterm labour.
    Papatsonis D; Flenady V; Cole S; Liley H
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
    Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial.
    Thongchan S; Phupong V
    BMC Pregnancy Childbirth; 2021 Jan; 21(1):90. PubMed ID: 33509129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys.
    Aye ILMH; Moraitis AA; Stanislaus D; Charnock-Jones DS; Smith GCS
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1056-1067. PubMed ID: 29293998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of an Oxytocin Receptor Antagonist (Retosiban, GSK221149A) on the Response of Human Myometrial Explants to Prolonged Mechanical Stretch.
    Moraitis AA; Cordeaux Y; Charnock-Jones DS; Smith GC
    Endocrinology; 2015 Oct; 156(10):3511-6. PubMed ID: 26207346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
    Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preterm delivery.
    Simhan HN; Caritis SN
    N Engl J Med; 2007 Aug; 357(5):477-87. PubMed ID: 17671256
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
    Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
    Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
    Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
    Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
    Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour.
    Papatsonis D; Flenady V; Liley H
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005938. PubMed ID: 19160259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.